γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells. (Q39463034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973114%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973114%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

author name string

S V Bachawal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

P W Sylvester

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

publication date

4 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973114%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

page(s)

516-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

ERBB receptors and cancer: the complexity of targeted inhibitors

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

c-Met: structure, functions and potential for therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

The MET axis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

The Met tyrosine kinase receptor in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

MET receptor tyrosine kinase as a therapeutic anticancer target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

MET pathway as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Showering c-MET-dependent cancers with drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Inhibition of proliferation and induction of apoptosis by gamma-tocotrienol in human colon carcinoma HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Epithelial cell line and subline established from premalignant mouse mammary tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

The function, proteolytic processing, and histopathology of Met in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

The value of tocotrienols in the prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

21 January 2018

Vitamin E and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

MET molecular mechanisms and therapies in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Signaling networks assembled by oncogenic EGFR and c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

EGFR/Met association regulates EGFR TKI resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2184.2011.00785.X

Selection and characterization in culture of mammary tumor cells with distinctive growth properties in vivo

21 January 2018

1 reference

12 December 2020

The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

1 reference

12 December 2020

Targeting the c-MET signaling pathway for cancer therapy

1 reference

12 December 2020

Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells

1 reference

12 December 2020

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma

1 reference

12 December 2020

Targeting ErbB receptor signaling: a pan-ErbB approach to cancer

1 reference

12 December 2020

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells

1 reference

12 December 2020

Inhibition of HGF/MET as therapy for malignancy

1 reference

12 December 2020

Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.

1 reference

12 December 2020

Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity

1 reference

12 December 2020

Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells

1 reference

12 December 2020

10.1111/J.1365-2184.2011.00785.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6496869&resulttype=core&format=json

14 May 2020

1 reference